Invasive candidiasis (IC) remains the most common invasive mycosis world-wide, responsible for a wide range of infections that can range from superficial mucosal infections to life-threatening systemic diseases. Clinical trials of antifungal agents for IC are pivotal to its management. Therapeutic responses in these tr...
J. Vazquez, S. C. Chen, S. Shoham et al.· Clinical Infectious Diseases· 0 citations
Posaconazole is a broad-spectrum antifungal agent used to manage invasive fungal infections (IFIs), particularly in high-risk immunocompromised patients. It is active against a range of fungal pathogens, including Candida spp., Aspergillus spp., and Mucorales. The introduction of delayed-release tablets and intravenous...
H. Akalın, S. Arıkan-Akdağlı, M. Ar et al.· Infectious Diseases and Clin...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.